Keine Story von Encysive Pharmaceuticals mehr verpassen.

Encysive Pharmaceuticals

08.09.2004 – 13:43

Thelin May Offer Alternative for PAH Patients Who Have Failed on Bosentan, According to Data Presented at European Respiratory Society Congress

Houston (ots/PRNewswire) - - Study Shows Liver Toxicities Experienced by Patients on Bosentan Were Not Experienced on Thelin Encysive Pharmaceuticals (Nasdaq: ENCY) today announced the presentation of new clinical data on Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European ...

mehr

1